VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_22-vv-00189 Package ID: USCOURTS-cofc-1_22-vv-00189 Petitioner: Jacki Della Rosa Carron Filed: 2022-02-22 Decided: 2023-11-13 Vaccine: influenza Vaccination date: 2020-09-19 Condition: acute inflammatory demyelinating polyneuropathy (AIDP) and chronic inflammatory demyelinating polyneuropathy (CIDP) Outcome: compensated Award amount USD: 75000 AI-assisted case summary: Jacki Della Rosa Carron filed a petition on February 22, 2022, seeking compensation under the National Vaccine Injury Compensation Program. She alleged that she suffered acute inflammatory demyelinating polyneuropathy (AIDP) and chronic inflammatory demyelinating polyneuropathy (CIDP) as a result of receiving an influenza vaccine on September 19, 2020. Petitioner further alleged that she experienced residual effects of this injury for more than six months. The respondent denied that the influenza vaccine caused Petitioner's conditions or that her current condition was a sequela of a vaccine-related injury. Despite maintaining their positions, both parties agreed to settle the case. A stipulation was filed on October 13, 2023, which the court adopted as its decision. The stipulation awarded Jacki Della Rosa Carron a lump sum of $75,000.00, representing compensation for all damages available under the Act. Chief Special Master Brian H. Corcoran issued the decision on November 13, 2023. The public decision does not describe the onset of symptoms, specific clinical details, diagnostic tests, treatments, or expert witnesses. Petitioner was represented by Simina Vourlis, and Respondent was represented by Rachelle Bishop. Theory of causation field: Petitioner Jacki Della Rosa Carron alleged that she suffered acute inflammatory demyelinating polyneuropathy (AIDP) and chronic inflammatory demyelinating polyneuropathy (CIDP) as a result of receiving an influenza vaccine on September 19, 2020, and experienced residual effects for more than six months. Respondent denied causation. The parties reached a stipulation for settlement, which was adopted by the court as its decision. The stipulation awarded Petitioner $75,000.00 in a lump sum. The public decision does not specify the theory of causation, medical experts, or the mechanism of injury. The decision was issued by Chief Special Master Brian H. Corcoran on November 13, 2023. Petitioner's counsel was Simina Vourlis, and Respondent's counsel was Rachelle Bishop. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_22-vv-00189-0 Date issued/filed: 2023-11-13 Pages: 7 Docket text: PUBLIC DECISION (Originally filed: 10/17/2023) regarding 42 DECISION Stipulation/Proffer. Signed by Chief Special Master Brian H. Corcoran. (mva) Service on parties made. -------------------------------------------------------------------------------- Case 1:22-vv-00189-UNJ Document 51 Filed 11/13/23 Page 1 of 7 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 22-189V * * * * * * * * * * * * * * * * * * * * * * * * * * JACKI DELLA ROSA CARRON, * Chief Special Master Corcoran * Petitioner, * Filed: October 17, 2023 * v. * * SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * * * * * * * * * * * * * Simina Vourlis, Law Offices of Simina Vourlis, Columbus, OH, for Petitioner. Rachelle Bishop, U.S. Dep’t of Justice, Washington, DC, for Respondent. DECISION AWARDING DAMAGES1 On February 22, 2022, Jacki Della Rosa Carron filed a petition seeking compensation under the National Vaccine Injury Compensation Program (the “Vaccine Program”).2 Petitioner alleges that she suffered acute inflammatory demyelinating polyneuropathy (“AIDP”) and chronic inflammatory demyelinating polyneuropathy (“CIDP”) as a result of her September 19, 2020, receipt of the influenza (“flu”) vaccine. Moreover, Petitioner alleges that she experienced residual effects of this injury for more than six months. Respondent denies that the flu vaccine caused Petitioner to suffer AIDP, CIDP, or any other injury or condition. Respondent also denies that Petitioner’s current condition is a sequela of a vaccine-related injury. Nonetheless both parties, while maintaining their above-stated positions, 1 Under Vaccine Rule 18(b), each party has fourteen (14) days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public in its present form. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”). Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix). Case 1:22-vv-00189-UNJ Document 51 Filed 11/13/23 Page 2 of 7 agreed in a stipulation (filed on October 13, 2023) that the issues before them could be settled, and that a decision should be entered awarding Petitioner compensation. I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation (as attached hereto) is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth therein. The stipulation awards: • A lump sum of $75,000.00 in the form of a check payable to Petitioner. Stipulation ¶ 8. This amount represents compensation for all damages that would be available under Section 15(a) of the Act. I approve a Vaccine Program award in the requested amount set forth above to be made to Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of the Court is directed to enter judgment herewith.3 IT IS SO ORDERED. /s/ Brian H. Corcoran Brian H. Corcoran Chief Special Master 3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by each filing (either jointly or separately) a notice renouncing their right to seek review. Case 1:22-vv-00189-UNJ Document 51 Filed 11/13/23 Page 3 of 7 Case 1:22-vv-00189-UNJ Document 51 Filed 11/13/23 Page 4 of 7 Case 1:22-vv-00189-UNJ Document 51 Filed 11/13/23 Page 5 of 7 Case 1:22-vv-00189-UNJ Document 51 Filed 11/13/23 Page 6 of 7 Case 1:22-vv-00189-UNJ Document 51 Filed 11/13/23 Page 7 of 7